Elizabeth A. Roundhill

St. James's University Hospital
Leeds, ENG LS97TF, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Characterisation of Bespoke Patient-Derived In Vitro Models of Ewing Sarcoma.

Characterisation of Bespoke Patient-Derived In Vitro Models of Ewing Sarcoma.

Journal: Cancers

Published: December 18, 2025

Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma.

Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma.

Journal: Cancers

Published: September 03, 2025

Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcoma.

Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcoma.

Journal: bioRxiv : the preprint server for biology

Published: June 06, 2025

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Journal: Molecular cancer therapeutics

Published: April 29, 2025

Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.

Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 09, 2024

Reply to: Comment on: Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma.

Reply to: Comment on: Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma.

Journal: Pediatric blood & cancer

Published: December 20, 2022

Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.

Clinical trials in cancer screening, prevention and early diagnosis (SPED): a systematic mapping review.

Journal: BMC cancer

Published: December 14, 2022

Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates.

Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates.

Journal: Cancers

Published: November 07, 2022

Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma.

Membrane-type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma.

Journal: Pediatric blood & cancer

Published: January 23, 2022

RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.

RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: June 11, 2021

CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.

CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.

Journal: Biochemical pharmacology

Published: November 12, 2019

ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.

ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.

Journal: Cancer letters

Published: September 11, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026